Related Experiment Video
Updated: Aug 11, 2026
06:32
Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
Published on: August 18, 2023
Where is the immunology in cancer?
The Australian and New Zealand Journal of Surgery
|February 1, 1978
Summary
The crucial question of whether human cancers have tumor-specific antigens eliciting an immune response remains unanswered. Current research models and in vitro assays for assessing host response in tumor immunology require significant refinement for valid clinical application.
Area of Science:
- Tumor immunology
- Cancer research
- Immunology
Background:
- The existence of tumor-specific antigens in human cancers and their ability to elicit a host immune response is a critical, unresolved question in tumor immunology.
- Recent discussions suggest that much prior research in this area may be invalid due to methodological limitations.
Purpose of the Study:
- To analyze the reasons behind the confusion in tumor immunology research.
- To evaluate the adequacy of current models and in vitro assays used to study human cancer and host immune responses.
Main Methods:
- Comparative analysis of established experimental data with human cancer characteristics.
- Critical review of in vitro assay methodologies for assessing host immune responses in cancer.
Main Results:
- Significant confusion in tumor immunology research is attributed to the use of inadequate models for studying human cancer.
- In vitro assays assessing host response have been inadequately evaluated, compromising the validity of previous findings.
Conclusions:
- Current methods for studying tumor-specific antigens and host immune responses in human cancer require substantial refinement or the development of new techniques.
- There are no apparent recent major advances in tumor immunology that are ready for clinical application.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...